{"public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "entities": {"mentions": [{"start": 0, "end": 15, "username": "RachelAlter007", "id": "3399916539"}], "urls": [{"start": 235, "end": 258, "url": "https://t.co/5YNlD8IIIG", "expanded_url": "https://www.targetedonc.com/view/leronlimab-shows-further-promise-for-covid-19-treatment-study-shows", "display_url": "targetedonc.com/view/leronlima\u2026"}], "hashtags": [{"start": 259, "end": 270, "tag": "leronlimab"}, {"start": 271, "end": 279, "tag": "covid19"}]}, "in_reply_to_user_id": "3399916539", "text": "@RachelAlter007 To disseminate results that can inform the public health in response to COVID-19, CytoDyn announced these findings in a pre-print manuscript, which has been submitted for publication and is currently under peer review.\nhttps://t.co/5YNlD8IIIG #leronlimab #covid19", "reply_settings": "everyone", "created_at": "2020-05-10T14:50:50.000Z", "source": "Twitter for Android", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "author_id": "999664767852625920", "referenced_tweets": [{"type": "replied_to", "id": "1258185264377274369"}], "id": "1259496122604646401", "lang": "en", "possibly_sensitive": false, "conversation_id": "1258185264377274369"}